Cargando…

Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report

BACKGROUND: Baclofen is a centrally acting GABA(B) receptor agonist and it is used widely for the treatment of spasticity, persistent hiccups and multiple sclerosis. The renal system is the main route of excretion, thus people with suboptimal renal function are prone to baclofen intoxication. Multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Khazneh, Emad, Shamlawi, Alaa, Jebrin, Kamel, Hamdan, Zakaria, Sawalmeh, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288861/
https://www.ncbi.nlm.nih.gov/pubmed/30537935
http://dx.doi.org/10.1186/s12882-018-1167-z
_version_ 1783379872471580672
author Khazneh, Emad
Shamlawi, Alaa
Jebrin, Kamel
Hamdan, Zakaria
Sawalmeh, Osama
author_facet Khazneh, Emad
Shamlawi, Alaa
Jebrin, Kamel
Hamdan, Zakaria
Sawalmeh, Osama
author_sort Khazneh, Emad
collection PubMed
description BACKGROUND: Baclofen is a centrally acting GABA(B) receptor agonist and it is used widely for the treatment of spasticity, persistent hiccups and multiple sclerosis. The renal system is the main route of excretion, thus people with suboptimal renal function are prone to baclofen intoxication. Multiple doses of baclofen have been associated with toxicity, but it is very unusual that single dose can do so. CASE PRESENTATION: A 47 year old female patient with end stage renal disease (ESRD) presented with a sudden onset of altered mental status and state of unconsciousness after the ingestion of one tablet of baclofen 25 mg. All other possible causes were ruled out and a diagnosis of baclofen toxicity was considered. The patient showed dramatic improvement after an extra two sessions of hemodialysis. CONCLUSIONS: We highly recommend that more educational efforts are made for health care professionals about the possible risk of baclofen toxicity among kidney-impaired patients. We also recommend avoiding baclofen use if evidence of chronic renal disease is present and to seek other alternatives for pain management.
format Online
Article
Text
id pubmed-6288861
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62888612018-12-14 Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report Khazneh, Emad Shamlawi, Alaa Jebrin, Kamel Hamdan, Zakaria Sawalmeh, Osama BMC Nephrol Case Report BACKGROUND: Baclofen is a centrally acting GABA(B) receptor agonist and it is used widely for the treatment of spasticity, persistent hiccups and multiple sclerosis. The renal system is the main route of excretion, thus people with suboptimal renal function are prone to baclofen intoxication. Multiple doses of baclofen have been associated with toxicity, but it is very unusual that single dose can do so. CASE PRESENTATION: A 47 year old female patient with end stage renal disease (ESRD) presented with a sudden onset of altered mental status and state of unconsciousness after the ingestion of one tablet of baclofen 25 mg. All other possible causes were ruled out and a diagnosis of baclofen toxicity was considered. The patient showed dramatic improvement after an extra two sessions of hemodialysis. CONCLUSIONS: We highly recommend that more educational efforts are made for health care professionals about the possible risk of baclofen toxicity among kidney-impaired patients. We also recommend avoiding baclofen use if evidence of chronic renal disease is present and to seek other alternatives for pain management. BioMed Central 2018-12-11 /pmc/articles/PMC6288861/ /pubmed/30537935 http://dx.doi.org/10.1186/s12882-018-1167-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Khazneh, Emad
Shamlawi, Alaa
Jebrin, Kamel
Hamdan, Zakaria
Sawalmeh, Osama
Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report
title Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report
title_full Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report
title_fullStr Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report
title_full_unstemmed Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report
title_short Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report
title_sort single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288861/
https://www.ncbi.nlm.nih.gov/pubmed/30537935
http://dx.doi.org/10.1186/s12882-018-1167-z
work_keys_str_mv AT khaznehemad singledosebaclofeninducedneurotoxicityinapatientwithendstagerenaldiseasecasereport
AT shamlawialaa singledosebaclofeninducedneurotoxicityinapatientwithendstagerenaldiseasecasereport
AT jebrinkamel singledosebaclofeninducedneurotoxicityinapatientwithendstagerenaldiseasecasereport
AT hamdanzakaria singledosebaclofeninducedneurotoxicityinapatientwithendstagerenaldiseasecasereport
AT sawalmehosama singledosebaclofeninducedneurotoxicityinapatientwithendstagerenaldiseasecasereport